Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 6, 2009, Pages 677-687

  Eadala, P ^a,b   Waud, J P ^a   Matthews, S B ^a   Green, J T ^b   Campbell, A K ^c  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b Department of Gastroenterology ^*  (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIEMETIC AGENT; ATROPINE PLUS DIPHENOXYLATE; AZATHIOPRINE; BALSALAZIDE; BISACODYL; BUDENOFALK; BUDESONIDE; CITALOPRAM; COCODAMOL; CODEINE PHOSPHATE; CODYDRAMOL; COLESTYRAMINE; COLOFAC; CORTICOSTEROID; CYCLOSPORIN A; DELTA CORTIL; DEXCEL; DICYCLOVERINE; DIOCTYL; DIVISTYRAMINE; DOMPERIDONE; ESOMEPRAZOLE; EXCIPIENT; FAMOTIDINE; FRUCTOSE; GASTROINTESTINAL AGENT; GLUCOSE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMODIUM INSTANT MELTS; IMMUNOSUPPRESSIVE AGENT; KREON; LACTOSE; LACTULOSE; LANSOPRAZOLE; LAXATIVE; LOPERAMIDE; MACROGOL 3350; MALTOSE; MEBEVERINE; MERCAPTOPURINE; MESALAZINE; MESREN; METHOTREXATE; METHYLCELLULOSE; METOCLOPRAMIDE; MISOPROSTOL; MUSCARINIC RECEPTOR BLOCKING AGENT; NIZATIDINE; NORTRIPTYLINE; OLSALAZINE; OMEPRAZOLE; PANCREATIN; PARACETAMOL; PEPPERMINT OIL; PICOSULFATE SODIUM; PREDNISOLONE; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; PROPANTHELINE BROMIDE; PROSTAGLANDIN DERIVATIVE; PROTIUM; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SALAZOSULFAPYRIDINE; SCOPOLAMINE BUTYL BROMIDE; SENOKOT; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; SUCRALFATE; SUCROSE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; URSOGAL; VALUPAK; VITAMIN; ZOTON FASTAB;

ARTICLE; DRUG FORMULARY; DRUG FORMULATION; GASTROINTESTINAL DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTOSE INTOLERANCE; PRESCRIPTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE;

CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; GASTROINTESTINAL DISEASES; HUMANS; LACTOSE; LACTOSE INTOLERANCE;

EID: 60349083113     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03889.x     Document Type: Article

References (49)

1. Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance. Sci Prog 2005 88 : 157 202.
2. Solomons NW. Fermentation, fermented foods and lactose intolerance. Eur J Clin Nutr 2002 56 (Suppl. 4 S50 5.
3. Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol Suppl 1994 202 : 7 20.
4. Swallow DM. Genetics of lactase persistence and lactose intolerance. Annu Rev Genet 2003 37 : 197 219.
5. Kuokkanen M, Kokkonen J, Enattah NS, et al. Mutations in the translated region of the lactase gene (LCT) underlie congenital lactase deficiency. Am J Hum Genet 2006 78 : 339 44.
6. Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988 48 (4 Suppl. 1079 159.
7. Crittenden RG, Bennett LE. Cow's milk allergy: a complex disorder. J Am Coll Nutr 2005 24 (6 Suppl. 582S 91S.
8. Host A. Frequency of cow's milk allergy in childhood. Ann Allergy Asthma Immunol 2002 89 (6 Suppl. 1 33 7.
9. He T, Priebe MG, Harmsen HJ, et al. Colonic fermentation may play a role in lactose intolerance in humans. J Nutr 2006 136 : 58 63.
10. Matthews SB, Waud JP, Roberts AG, Campbell AK. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 2005 81 : 167 73.
11. Grimbacher B, Peters T, Peter HH. Lactose-intolerance may induce severe chronic eczema. Int Arch Allergy Immunol 1997 113 : 516 8.
12. Matthews SB, Campbell AK. When sugar is not so sweet. Lancet 2000 355 : 1330.
13. Tsuruta D, Sowa J, Kobayashi H, Ishii M. Fixed food eruption caused by lactose identified after oral administration of four unrelated drugs. J Am Acad Dermatol 2005 52 : 370 1.
14. Christopher NL, Bayless TM. Role of the small bowel and colon in lactose-induced diarrhea. Gastroenterology 1971 60 : 845 52.
15. 2+ channels. Cell Calcium 2007 41 : 97 106.
16. Newcomer AD, McGill DB, Thomas PJ, Hofmann AF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med 1975 293 : 1232 6.
17. Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol Suppl 1994 202 : 26 35.
18. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I. Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002 30 : 233 7.
19. Waud JP, Matthews SB, Campbell AK. Measurement of breath hydrogen and methane, together with lactase genotype, defines the current best practice for investigation of lactose sensitivity. Ann Clin Biochem 2008 45 : 50 8.
20. Bolhuis GK, Armstrong NA. Excipients for direct compaction - an update. Pharm Dev Technol 2006 11 : 111 24.
21. Gunsel WC, Lachman L. Comparative evaluation of tablet formulations prepared from conventionally-processed and spray-dried lactose. J Pharm Sci 1963 52 : 178 82.
22. Rusynyk RA, Still CD. Lactose intolerance. J Am Osteopath Assoc 2001 101 (4 Suppl. S10 2.
23. Casterline JL Jr., Oles CJ, Ku Y. Measurement of sugars and starches in foods by a modification of the AOAC total dietary fiber method. J AOAC Int 1999 82 : 759 65.
24. Wade OL. British National Formulary: its birth, death, and rebirth. BMJ 1993 306 : 1051 4.
25. Suarez FL, Savaiano DA, Levitt MD. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995 333 : 1 4.
26. Brandstetter RD, Conetta R, Glazer B. Lactose intolerance associated with Intal capsules. N Engl J Med 1986 315 : 1613 4.
27. Lieb J, Kazienko DJ. Lactose filler as a cause of "drug- induced" diarrhea. N Engl J Med 1978 299 : 314.
28. Petrini L, Usai P, Caradonna A, Cabula R, Mariotti S. Lactose intolerance following antithyroid drug medications. J Endocrinol Invest 1997 20 : 569 70.
29. Zarbock SD, Magnuson B, Hoskins L, Record KE, Smith KM. Lactose: the hidden culprit in medication intolerance? Orthopedics 2007 30 : 615 7.
30. "Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs. Pediatrics 1997 99 : 268 78.
31. Malen DG. Parnate formulation change. J Clin Psychiatry 1992 53 : 328 9.
32. Farup PG, Monsbakken KW, Vandvik PO. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol 2004 39 : 645 9.
33. Bohmer CJ, Tuynman HA. The clinical relevance of lactose malabsorption in irritable bowel syndrome. Eur J Gastroenterol Hepatol 1996 8 : 1013 6.
34. Parker TJ, Woolner JT, Presvost AT, Tuffnell Q, Shorthouse M, Hunter JO. Irritable bowel syndrome: is the search for lactose intolerance justified? Eur J Gastroenterol Hepatol 2001 13 : 219 25.
35. Alpers DH. Diet and irritable bowel syndrome. Curr Opin Gastroenterol 2006 22 : 136 9.
36. Vesa TH, Seppo LM, Marteau PR, Sahi T, Korpela R. Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr 1998 67 : 710 5.
37. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006 55 : 1037 46.
38. Bode S, Gudmand-Hoyer E. Incidence and clinical significance of lactose malabsorption in adult coeliac disease. Scand J Gastroenterol 1988 23 : 484 8.
39. Ojetti V, Nucera G, Migneco A, et al. High prevalence of celiac disease in patients with lactose intolerance. Digestion 2005 71 : 106 10.
40. von Tirpitz C, Kohn C, Steinkamp M, et al. Lactose intolerance in active Crohn's disease: clinical value of duodenal lactase analysis. J Clin Gastroenterol 2002 34 : 49 53.
41. Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol 1997 92 : 1148 53.
42. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr 1997 65 : 564 7.
43. Banos Madrid R, Salama Benerroch H, Moran Sanchez S, Gallardo Sanchez F, Albadalejo Merono A, Mercader Martinez J. Lactose malabsorption in patients with inflammatory bowel disease without activity: would it be necessary to exclude lactose products in the diet of all patients?. An Med Interna 2004 21 : 212 4.
44. Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol 1994 89 : 872 7.
45. Buning C, Ockenga J, Kruger S, et al. The C/C(-13910) and G/G(-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease. Scand J Gastroenterol 2003 38 : 538 42.
46. Shonde A, Andreyev HJ. The role of radiological imaging in the patient with gastrointestinal symptoms after pelvic radiotherapy. Cancer Imaging 2004 4 : 92 4.
47. Wedlake L, Thomas K, McGough C, Andreyev HJ, et al. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: an observational study. Eur J Cancer 2008 44 : 2212 7.
48. Rasinpera H, Forsblom C, Enattah NS, et al. The C/C-13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish population. Gut 2005 54 : 643 7.
49. Lomer MC, Parkes GC, Sanderson JD. Review article: lactose intolerance in clinical practice - myths and realities. Aliment Pharmacol Ther 2008 27 : 93 103.